Dividend Informer Q1 2025 Update: Abbott Laboratories

Results were in line with the Street's estimates. Management maintained its guidance for 2025 after hinting at the possibility of an even better outlook.

Apr 23, 2025

∙ Paid

⚠️This news update is exclusive to paid Dividend Informer subscribers. Here is our team’s update on a covered stock. See below for updated buy/sell prices, a report on recent conditions and expectati…

Dividend Informer Q1 2025 Update: Abbott Laboratories

Results were in line with the Street's estimates. Management maintained its guidance for 2025 after hinting at the possibility of an even better outlook.

This post is for paid subscribers